Skip to main content
. 2022 Mar 21;13:116. doi: 10.1186/s13287-022-02804-4

Fig. 1.

Fig. 1

Protocol of the study. Legend: TAO, thromboangiitis obliterans; SLE, systemic lupus erythematosus; HES, hypereosinophilic syndrome; PBMNCs, peripheral blood mononuclear cells; PCCs, purified CD34+ cells